EnvironmentGuru
Search
Search

Biology


(Re)Building a Kidney (UC2 Clinical Trial Not Allowed)

Grants.gov

Funding Opportunity ID: 318661Opportunity Number: RFA-DK-19-007Opportunity Title:(Re)Building a Kidney (UC2 Clinical Trial Not

9/20/2019

Preclinical Screening for Natural Product Drug Interactions (Clinical

Grants.gov

Funding Opportunity ID: 318739Opportunity Number: RFA-AT-20-001Opportunity Title:Preclinical Screening for Natural Product Drug Interactions

9/20/2019

Global Polyaniline (PANI) Market Professional Survey 2019 by

ReportsNReports

The Polyaniline (PANI) market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the

9/20/2019

Global Monascus Pigment Market Professional Survey 2019 by

ReportsNReports

The Monascus Pigment market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the

9/20/2019

Global Isolongifolenone (CAS 23747-14-0) Market Professional Survey

ReportsNReports

The Isolongifolenone (CAS 23747-14-0) market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of

9/20/2019

Artificial Cells Sense and Respond to Their Environment for Drug

Design News

Researchers have made a breakthrough in developing artificial cells that can mimic biological cells for next-generation biotechnology

9/20/2019

HealthTech &Number 039 urban-air commuting&Number 039 startups among

University of Waterloo

Friday, September 20, 2019 Startups in the fields of biotechnology, energy and urban-air commuting were among the winners of the Velocity Fund

9/20/2019

Chemistry / M2 Pharma "Genentech Presents New Six-year Ocrevus

Free Library

M2 PHARMA-September 18, 2019-Genentech Presents New Six-year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of

9/18/2019

Stealth BioTherapeutics to Attend Upcoming Investor Conferences

PR Newswire

BOSTON, Sept. 20, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the

9/20/2019
Cold plasma technology promises to blow tumours away

Cold plasma technology promises to blow tumours away

The Engineer

Clinical trials are to start on a cold atmospheric plasma technology that effectively removes microscopic cancer tumours remaining from surgery.

8/21/2019

Top Tags

agar Biotechnology In Vitro In Vivo Cloning DNA sequencing Monoclonal Antibodies adenovirus actin Recombinant DNA agarose gel electrophoresis Genetic Engineering acellular Abiotic Stress adenine affinity tag DNA Hybridization aerobic respiration 
Cold plasma technology promises to blow tumours away

Biology

Cold plasma technology promises to blow tumours away

ASAP Benchmarking the in Vitro Toxicity and Chemical Composition of Plastic

Biology

ASAP Benchmarking the in Vitro Toxicity and Chemical Composition of Plastic

Jon White – From the President’s Office: 09-16-2019

Biology

Jon White – From the President’s Office: 09-16-2019

An explosion rocked a Russian research facility known for housing the 

Biology

An explosion rocked a Russian research facility known for housing the 

ASAP In Vitro Metabolic Stability of a Casein-Derived Dipeptidyl

Biology

ASAP In Vitro Metabolic Stability of a Casein-Derived Dipeptidyl

ASAP In Vitro Metabolic Stability of a Casein-Derived Dipeptidyl

Biology

ASAP In Vitro Metabolic Stability of a Casein-Derived Dipeptidyl